What was the overall valuation of the GCC pharmacy market in 2024?

The overall market valuation was $55.55 Billion in 2024. Read More

What is the projected market valuation for the GCC pharmacy market by 2035?

The projected valuation for 2035 is $91.13 Billion. Read More

What is the expected CAGR for the GCC pharmacy market from 2025 to 2035?

The expected CAGR during the forecast period 2025 - 2035 is 4.6%. Read More

Which product type segment had the highest valuation in 2024?

In 2024, the Prescription Drugs segment had the highest valuation at $22.22 Billion. Read More

What is the projected valuation for Over-The-Counter Drugs by 2035?

The projected valuation for Over-The-Counter Drugs by 2035 is $25.0 Billion. Read More

Which distribution channel is expected to grow the most by 2035?

The Online Pharmacy distribution channel is expected to grow to $20.0 Billion by 2035. Read More

What therapeutic area is projected to have the highest valuation in 2035?

The Infectious Diseases therapeutic area is projected to reach $29.13 Billion by 2035. Read More

What formulation type is expected to see significant growth by 2035?

The Tablets formulation type is expected to grow to $32.0 Billion by 2035. Read More

Who are the key players in the GCC pharmacy market?

Key players include CVS Health, Walgreens Boots Alliance, Roche, and McKesson. Read More

What was the valuation of the Specialty Pharmacy segment in 2024?

The Specialty Pharmacy segment was valued at $8.33 Billion in 2024. Read More

GCC Pharmacy Market

ID: MRFR/Pharma/50766-HCR

200 Pages

Nidhi Mandole

Last Updated: April 06, 2026

GCC Pharmacy Market Research Report By Product Type (Prescription Drugs, Over-The-Counter Drugs, Vaccines, Homeopathic Medicine), By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, Online Pharmacy, Specialty Pharmacy), By Therapeutic Area (Cardiovascular, Oncology, Diabetes, Neurology, Infectious Diseases) and By Formulation (Tablets, Injectables, Topicals, Liquids) - Growth & Industry Forecast 2025 To 2035

GCC Pharmacy Market

Market Size

Forecast Period2025 - 2035

CAGR (2025 - 2035)4.6%

2024 Market Size$ 55.55 Billion

2025 Market Size$ 58.11 Billion

2035 Market Size$ 91.13 Billion

Key Players

CVS Health

Walgreens Boots Alliance

Roche

McKesson

Cigna

Cardinal Health

Trends

Digital Transformation in Pharmacy Services
Focus on Preventive Healthcare
Regulatory Support for Local Manufacturing

Opportunities

Increased Focus on Personalized Medicine
Integration of Health Technology Solutions
Expansion of E-commerce in Pharmacy Services

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Life Sciences, BY Product Type (USD Billion)
  1. 4.1.1 Prescription Drugs
  2. 4.1.2 Over-The-Counter Drugs
  3. 4.1.3 Vaccines
  4. 4.1.4 Homeopathic Medicine
2. 4.2 Life Sciences, BY Distribution Channel (USD Billion)
  1. 4.2.1 Retail Pharmacy
  2. 4.2.2 Hospital Pharmacy
  3. 4.2.3 Online Pharmacy
  4. 4.2.4 Specialty Pharmacy
3. 4.3 Life Sciences, BY Therapeutic Area (USD Billion)
  1. 4.3.1 Cardiovascular
  2. 4.3.2 Oncology
  3. 4.3.3 Diabetes
  4. 4.3.4 Neurology
  5. 4.3.5 Infectious Diseases
4. 4.4 Life Sciences, BY Formulation (USD Billion)
  1. 4.4.1 Tablets
  2. 4.4.2 Injectables
  3. 4.4.3 Topicals
  4. 4.4.4 Liquids
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Life Sciences
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Life Sciences
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 CVS Health (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Walgreens Boots Alliance (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Roche (CH)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 McKesson (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Cigna (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Cardinal Health (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 AstraZeneca (GB)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Sanofi (FR)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 GSK (GB)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
  10. 5.2.10 Bristol-Myers Squibb (US)
    1. 5.2.10.1 Financial Overview
    2. 5.2.10.2 Products Offered
    3. 5.2.10.3 Key Developments
    4. 5.2.10.4 SWOT Analysis
    5. 5.2.10.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 GCC MARKET ANALYSIS BY PRODUCT TYPE
3. 6.3 GCC MARKET ANALYSIS BY DISTRIBUTION CHANNEL
4. 6.4 GCC MARKET ANALYSIS BY THERAPEUTIC AREA
5. 6.5 GCC MARKET ANALYSIS BY FORMULATION
6. 6.6 KEY BUYING CRITERIA OF LIFE SCIENCES
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF LIFE SCIENCES
9. 6.9 DRIVERS IMPACT ANALYSIS: LIFE SCIENCES
10. 6.10 RESTRAINTS IMPACT ANALYSIS: LIFE SCIENCES
11. 6.11 SUPPLY / VALUE CHAIN: LIFE SCIENCES
12. 6.12 LIFE SCIENCES, BY PRODUCT TYPE, 2024 (% SHARE)
13. 6.13 LIFE SCIENCES, BY PRODUCT TYPE, 2024 TO 2035 (USD Billion)
14. 6.14 LIFE SCIENCES, BY DISTRIBUTION CHANNEL, 2024 (% SHARE)
15. 6.15 LIFE SCIENCES, BY DISTRIBUTION CHANNEL, 2024 TO 2035 (USD Billion)
16. 6.16 LIFE SCIENCES, BY THERAPEUTIC AREA, 2024 (% SHARE)
17. 6.17 LIFE SCIENCES, BY THERAPEUTIC AREA, 2024 TO 2035 (USD Billion)
18. 6.18 LIFE SCIENCES, BY FORMULATION, 2024 (% SHARE)
19. 6.19 LIFE SCIENCES, BY FORMULATION, 2024 TO 2035 (USD Billion)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 GCC MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
  2. 7.2.2 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  3. 7.2.3 BY THERAPEUTIC AREA, 2025-2035 (USD Billion)
  4. 7.2.4 BY FORMULATION, 2025-2035 (USD Billion)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

GCC Life Sciences Market Segmentation

Life Sciences By Product Type (USD Billion, 2025-2035)

Prescription Drugs
Over-The-Counter Drugs
Vaccines
Homeopathic Medicine

Life Sciences By Distribution Channel (USD Billion, 2025-2035)

Retail Pharmacy
Hospital Pharmacy
Online Pharmacy
Specialty Pharmacy

Life Sciences By Therapeutic Area (USD Billion, 2025-2035)

Cardiovascular
Oncology
Diabetes
Neurology
Infectious Diseases

Life Sciences By Formulation (USD Billion, 2025-2035)

Tablets
Injectables
Topicals
Liquids

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”